Chief Scientific Officer

Dr. Søren Morgenthaler Echwald has a strong scientific background from basic and clinical research combined with 15+ years in the biotech industry within business development, licensing and intellectual property.

Dr. Echwald’s research and application focus areas have been in genetics and microRNA and developing tools and reagents for the diagnostics industry. With this experience, scientific and executive roles at companies including Novo Nordisk, Exiqon A/S and Anapa Biotech A/S, and a PhD and post doc from the technical university in Denmark (DTU), Dr. Echwald’s has a unique skillset for identifying, evaluating and exploiting science-based business opportunities.

Dr. Echwald is an inventor of over 20 patent applications and author of more than 50 publications in peer reviewed scientific journals.